用保存的喷射分数治疗心力衰竭的重要一步
Subodh Verma1, Barry A Borlaug2, Javed Butler3
1Division of Cardiac Surgery, St. Michael's Hospital of Unity Health Toronto, Toronto, ON, Canada; Department of Surgery, University of Toronto, Toronto, ON, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada.
Cell metabolism
|August 29, 2023
概括
塞马格卢提德显著改善了肥胖患者和心力衰竭患者的心力衰竭症状和运动能力,并保留了喷射分数 (HFpEF). 针对肥胖症代表了HFpEF的新治疗方法.
科学领域:
- 心脏病学 心脏病学
- 代谢疾病 代谢疾病
- 肥胖医学 肥胖医学
背景情况:
- 肥胖是心力衰竭与保存的喷射分数 (HFpEF) 的一个显著的并发症.
- 目前对HFpEF的治疗策略有效性有限,特别是在肥胖患者中.
研究的目的:
- 评估塞马格卢提德在改善肥胖患者和HFpEF患者的临床结果方面的疗效.
- 评估塞马格卢提德对运动功能,体重和炎症的影响.
主要方法:
- 这项研究是双盲,安慰剂控制的STEP-HFpEF试验.
- 参与者接受了2.4毫克的塞马格卢提德或安慰剂.
- 关键的结果措施包括心力衰竭症状的变化,身体限制,运动能力,体重和炎症标志物.
主要成果:
- 塞马格卢提德显著改善了心力衰竭症状和身体限制.
- 随着塞马格卢提德治疗,运动功能的显著改善以及体重和炎症的减少被观察到.
- 这种治疗一般都能很好地忍受.
结论:
- 塞马格卢提德为肥胖患者管理HFpEF提供了一个有前途的治疗选择.
- 通过药物治疗准肥胖症代表了HFpEF治疗范式中的新有效策略.
相关概念视频
Heart Failure V: Medical Management
13
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
13
Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
Heart Failure IV: Classification and Diagnostic Evaluation
19
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
19
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
463
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
463
Cardiomyopathy V: Interprofessional Care
14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K


